BioPharmSignal logoBioPharmSignal

Biotech News

Apyx Medical Corporation to Participate in Upcoming Investor Conferences

Apyx Medical (APYX)Apyx MedicalCompany update

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will present at the following investor conferences:

Related news

APYXApyx Medical2026-10-22 12:00 EST

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

APYXApyx Medical2026-08-06 20:05 EST

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

SENSSenseonics2026-10-22 12:00 EST

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

SENSSenseonics2026-09-10 12:00 EST

Senseonics To Participate in Upcoming Institutional Investor Conferences

DCTHDelcath Systems2026-08-31 20:01 EST

Delcath Systems to Participate in Upcoming Investor Conferences

LMATLeMaitre Vascular2026-08-27 20:51 EST

LeMaitre to Participate at Upcoming Investor Conferences in September

LUNGPulmonx2026-08-27 20:05 EST

Pulmonx to Participate in Upcoming Investor Conferences

ICUIICU Medical2026-08-27 12:30 EST

ICU Medical to Participate in Upcoming Investor Conferences

MMSIMerit Medical2026-09-04 13:25 EST

Merit Medical to Participate in Upcoming Investors Conferences in September

ACHCAcadia Healthcare2026-09-09 13:00 EST

Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference

View all latest news

Apyx Medical

Surgical Aesthetics Apyx Medical develops energy-based systems used in cosmetic and surgical procedures. Its technology is intended to contract soft tissue and support body-contouring outcomes. Renuvion Renuvion combines helium plasma with radiofrequency energy for precise delivery beneath the skin. The platform is used by plastic and...

Recent company news

APYXApyx Medical2026-10-22 12:00 EST

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

APYXApyx Medical2026-10-21 12:00 EST

Apyx Medical Corporation to Participate in Upcoming Investor Conferences

APYXApyx Medical2026-09-29 12:00 EST

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

APYXApyx Medical2026-08-06 20:05 EST

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

APYXApyx Medical2026-07-28 12:00 EST

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Stock data

Close
2.51 USD
Market cap
161.21M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States